SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001453687-24-000082
Filing Date
2024-05-08
Accepted
2024-05-08 07:06:20
Documents
107
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rnac-20240331.htm   iXBRL 10-Q 1229156
2 EX-10.3(B) firstamendmenttoleaseagree.htm EX-10.3(B) 54715
3 EX-31.1 exhibit311_3312024.htm EX-31.1 10319
4 EX-31.2 exhibit312_3312024.htm EX-31.2 10261
5 EX-32.1 exhibit321_3312024.htm EX-32.1 9937
  Complete submission text file 0001453687-24-000082.txt   8790411

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20240331.xsd EX-101.SCH 78183
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rnac-20240331_cal.xml EX-101.CAL 82373
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnac-20240331_def.xml EX-101.DEF 459430
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20240331_lab.xml EX-101.LAB 841474
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20240331_pre.xml EX-101.PRE 673606
111 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20240331_htm.xml XML 1127738
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37798 | Film No.: 24924214
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)